High-sensitivity Cardiac Troponin T is More Helpful in Detecting Peri-operative Myocardial Injury and Apoptosis During Coronary Artery Bypass Graft Surgery
Overview
Authors
Affiliations
Aim: To determine whether there is a correlation between cardiac markers and peri-operative myocardial injury (PMI) and apoptosis in coronary artery bypass graft (CABG) surgery and to compare the efficacy of cardiac markers to detect PMI.
Methods: The study population consisted of 37 patients (24 male, 13 female, mean age 63.4 ± 8.9 years) undergoing elective CABG. Arterial and coronary sinus blood samples were collected just before aortic cross-clamping (pre-ACC) and after aortic declamping (post-ACC). Creatine kinase-MB isoenzyme (CK-MB) activity, and high-sensitivity cardiac troponin T (hs-cTnT), creatine kinase-MB isoenzyme mass (CK-MB mass) and cardiac troponin I (cTnI) concentrations were measured in blood samples. Myocardial injury and apoptosis were examined in atrial biopsies.
Results: CABG caused PMI and apoptosis in all cases. Concentrations and net releases of cardiac markers significantly increased after aortic declamping (p < 0.001 for CK-MB and CK-MB mass, p < 0.01 for cTnI, p < 0.05 for hs-cTnT). A positive correlation was found between apoptotic index (r = 0.611, p < 0.001 for cTnI; r = 0.806, p < 0.001 for hs-cTnT), myocardial injury score (r = 0.544, p < 0.001 for cTnI; r = 0.719, p < 0.001 for hs-cTnT) and cTnI and hs-cTnT values in the post-ACC period. A positive correlation was found between apoptotic index (r = 0.507, p < 0.001), myocardial injury score (r = 0.416, p = 0.010) and net release of hs-cTnT. Furthermore, a positive correlation was found between aortic cross-clamp (ACC) time (r = 0.448, p = 0.007), cardiopulmonary bypass (CPB) time (r = 0.342, p = 0.047) and net release of hs-cTnT.
Conclusion: Although both cTnI and hs-cTnT may be specific and efficacious markers of myocardial apoptosis and injury occurring during CABG with CPB, hs-cTnT may be a more useful marker than cTnI to detect peri-operative myocardial apoptosis and injury.
Taheri H, Chiti H, Reshadmanesh T, Gohari S, Jalilvand A, Arsang-Jang S J Diabetes Metab Disord. 2023; 22(2):1723-1730.
PMID: 37975102 PMC: 10638116. DOI: 10.1007/s40200-023-01305-2.
Sener E, Hamurcu Z, Taheri S, Tahtasakal R, Delibasi N, Elcik D Arq Bras Cardiol. 2023; 120(7):e20220479.
PMID: 37466618 PMC: 10364987. DOI: 10.36660/abc.20220479.
Parmana I, Boom C, Rachmadi L, Hanafy D, Widyastuti Y, Mansyur M Vasc Health Risk Manag. 2023; 19:93-101.
PMID: 36880009 PMC: 9985398. DOI: 10.2147/VHRM.S399925.
Parmana I, Boom C, Rachmadi L, Hanafy D, Widyastuti Y, Mansyur M Vasc Health Risk Manag. 2022; 18:219-231.
PMID: 35411147 PMC: 8994629. DOI: 10.2147/VHRM.S361298.
Gu Y, Shan L, Liu B, Lv M, Chen X, Yan T Int J Gen Med. 2021; 14:2541-2551.
PMID: 34163222 PMC: 8214547. DOI: 10.2147/IJGM.S315691.